SCHEMBL7703580

SCHEMBL7703580

O=C(O)Nc1cc(COC2CCCCO2)c(-c2ccc(F)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 3/20 0.38
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
ALDH1A1 P00352 5/20 0.36
MAPT P10636 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CREBBP Q92793 2/20 0.35
KMT2A Q03164 5/20 0.35
MEN1 O00255 3/20 0.35
EP300 Q09472 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139585 0.90 MMP8 (0.35) HCAR3HDAC3HDAC1HDAC2ALDH1A1
SCHEMBL7700574 0.87 ALDH1A1 (0.38) HCAR3ALDH1A1MAPTL3MBTL1NPC1
SCHEMBL7698563 0.82 HCAR3 (0.40) HCAR3ALDH1A1MAPTL3MBTL1NPC1
SCHEMBL7139514 0.77 CHRM3 (0.35) HCAR3ALDH1A1MAPTL3MBTL1NPC1
SCHEMBL7145150 0.76 ADRA2A (0.35) HCAR3ALDH1A1MAPTL3MBTL1CREBBP
SCHEMBL7141349 0.75 HDAC1 (0.45) HDAC3HDAC1HDAC2
SCHEMBL7289238 0.75 TTR (0.41) HCAR3ALDH1A1MAPTL3MBTL1SMN1; SMN2
SCHEMBL7144424 0.73 CHRM3 (0.36) ALDH1A1MAPT
SCHEMBL5563454 0.73 KMT2A (0.38) HCAR3ALDH1A1MAPTL3MBTL1SMN1; SMN2
SCHEMBL7700560 0.72 CREBBP (0.37) HDAC3HDAC1HDAC2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed